Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company in the United States that creates drug candidates for immune-inflammatory diseases. The company's Therapeutics and Contract Research segments are responsible for developing innovative therapies for unmet needs in the field of immuno-inflammatory diseases. Aclaris is currently working on several potential treatments for various ailments, including rheumatoid and psoriatic arthritis, atopic dermatitis, inflammatory bowel disease, and cancer.